What is the future outlook for Retatrutide in weight management
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice
Tirzepatide (MOUNJARO) Pronounced: tir ZEP a tide / mown JAHR OH Mnemonic: Tear zeppelin (over) Mount (Kiliman)jaro Year of release: 2022 Cost: $1060 / mo FDA-approved for: Type 2 diabetes Mechanism: dual GLP-1/GIP receptor agonist Available doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg (weekly subcutaneous injection) Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none significant in a bubble Tirzepatide (Mounjaro) is the first twincretin for type 2 diabetes
Factors that influence early weight loss include starting body weight, baseline diet quality, physical activity level, hydration status, and individual metabolic rate
Toxics 13, 594